North America
News from CMS, UnitedHealthGroup, Livongo and others.
The digital health mainstay closed its first day of trading roughly 40% above its set price, and looks forward to scaling its business as a public entity.
The suit alleges that only three of the nine STD tests sold by WebMD have undergone FDA approval process.
The company's executives lauded the CGM system, which saw a 72.9% increase in organic sales during the last quarter, and hinted at implementations of the tech beyond diabetes alone.
The app will let users scan a device's barcode to bring up safety information.
Mercom Capital Group's latest numbers also suggest that upcoming IPOs could cast a long shadow on the direction of digital health investing.
The round was led by 30Ventures with participation from Rise of the Rest Seed Fund and Flying Point Industries.
The company's products include an app-based service with original music and guided meditation content, and a cushion that pulses in sync with the audio.
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.